載入...
Catalytic Inhibitors of Topoisomerase II Differently Modulate the Toxicity of Anthracyclines in Cardiac and Cancer Cells
Anthracyclines (such as doxorubicin or daunorubicin) are among the most effective anticancer drugs, but their usefulness is hampered by the risk of irreversible cardiotoxicity. Dexrazoxane (ICRF-187) is the only clinically approved cardioprotective agent against anthracycline cardiotoxicity. Its act...
Na minha lista:
Main Authors: | , , , , , , , |
---|---|
格式: | Artigo |
語言: | Inglês |
出版: |
Public Library of Science
2013
|
主題: | |
在線閱讀: | https://ncbi.nlm.nih.gov/pmc/articles/PMC3792022/ https://ncbi.nlm.nih.gov/pubmed/24116135 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1371/journal.pone.0076676 |
標簽: |
添加標簽
沒有標簽, 成為第一個標記此記錄!
|